This section contains further information for our shareholders. Information about the disclaimer is available here.

Date of foundation

March 26, 1998

Accounting standard

International Financial Reporting Standard (IFRS)

End of financial year

31 December

   

As of October 28, 2016

Authorized Capital

100 Class A Voting Common shares; Unlimited Class B Voting Common Shares

Issued and Outstanding Stock

100 Class A Voting shares and 47,852,730 Class B Voting Shares

Paying and Depository Agent

WebStock Transfer Agency

Trading Platform

US: OTC Markets. Pink Current

Ticker Symbol

VRSYF

Investor notice

Only investors who have noted the above conditions and agree to be bound by them and investors who are normally resident outside the United States of America (USA) should continue with the information provided.

STOCK QUOTES are available on the sites (symbol VRSYF):

a. www.otcmarkets.com  
b. www.bloomberg.com
c. www.marketwatch.com

 

VMS GROUP

VMS Corporate Structure

“Nothing ranks higher than the trust and confidence we build with each and every investor”

To broaden the Company’s market reach and benefit from rapidly changing consumer trends in retail shopping, the Company formed its first European subsidiary in October 2017 to launch the Company’s private brand of quality of life products under the OrthoCush™ label. The new European subsidiary, VMS Rehab Polska sp z o.o. is based in Warsaw, Poland and is charged with the responsibility of providing management oversight for the production of a line of high performance Orthopedic seat cushions for global consumption. A new on line E-shop should go live before the year end 2017 to market VMS’ OrthoCush ™ seat cushions direct to the consumer, initially throughout the European Union.

 

Disclaimer

The information contained herein does not constitute an offer for sale or a solicitation for submission of an offer for purchase or subscription of shares and/or securities of any kind whatsoever in VMS Rehab Systems, Inc.. It is provided solely as information.

Not investment advice

The information contained herein does not constitute investment advice.

Forward-looking statements

Insofar as forecasts, estimates, opinions or expectations are expressed or forward-looking statements are made in the following information, these statements may involve known and unknown risks and uncertainties. The actual results and developments may therefore differ substantially from the expectations and assumptions expressed.

Risk investment

Investment in sector companies in the Healthcare and Pharmaceutical field can offer great opportunities but they inevitably involve correspondingly high risks. Investment in these companies should therefore, as a matter of principle, be classified as a risk investment. Loss of the sum invested cannot be ruled out. That is why this form of investment is in general better suited for diversification as part of a broader portfolio strategy.